Suchergebnisse - "Robillard, Liliane"

PubPharm (31)

1

Fibroblast activation protein targeted radiotherapy induces an immunogenic tumor microenvironment and enhances the efficacy of PD-1 immune checkpoint inhibition

enthalten in: European journal of nuclear medicine and molecular imaging | 2023

von Zboralski, D. | Osterkamp, F. | Christensen, E. | +11

2

Fibroblast activation protein targeted radiotherapy induces an immunogenic tumor microenvironment and enhances the efficacy of PD-1 immune checkpoint inhibition

enthalten in: European journal of nuclear medicine and molecular imaging | 2023

von Zboralski, D. | Osterkamp, F. | Christensen, E. | +11

3

Fibroblast activation protein targeted radiotherapy induces an immunogenic tumor microenvironment and enhances the efficacy of PD-1 immune checkpoint inhibition

enthalten in: European journal of nuclear medicine & molecular imaging | 2023

von Zboralski, D. | Osterkamp, F. | Christensen, E. | +11

4

Fibroblast activation protein targeted radiotherapy induces an immunogenic tumor microenvironment and enhances the efficacy of PD-1 immune checkpoint inhibition

enthalten in: European journal of nuclear medicine and molecular imaging | 2023

von Zboralski, D. | Osterkamp, F. | Christensen, E. | +11

5

The Multi-Kinase Inhibitor Lucitanib Enhances the Antitumor Activity of Coinhibitory and Costimulatory Immune Pathway Modulators in Syngeneic Models

enthalten in: Journal of immunotherapy (Hagerstown, Md. : 1997) | 2022

von Robillard, L. | Liao, M. | Nguyen, M. | +3

6

Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer

enthalten in: Nature medicine | 2019

von Shah, K. | Bhatt, R. | Rotow, J. | +22

CommentIn: Transl Cancer Res. 2019 Dec;8(Suppl 6):S564-S568. - PMID 35117132

7

Secondary Somatic Mutations Restoring RAD51C and RAD51D Associated with Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma

enthalten in: Cancer discovery | 2017

von Kondrashova, O. | Nguyen, M. | Shield-Artin, K. | +33

CommentIn: Cancer Discov. 2017 Sep;7(9):937-939. - PMID 28864639

8

Quantitative phosphoproteomic analysis of the PI3K-regulated signaling network

enthalten in: Proteomics | 2016

von Gnad, F. | Wallin, J. | Edgar, K. | +9

9

Quantitative phosphoproteomic analysis of the PI3K-regulated signaling network

enthalten in: Proteomics | 2016

von Gnad, F. | Wallin, J. | Edgar, K. | +9

10

Quantitative phosphoproteomic analysis of the PI3K‐regulated signaling network

enthalten in: Proteomics | 2016

von Gnad, F. | Wallin, J. | Edgar, K. | +9